Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy

被引：0

作者：

Siveke, J. T. ^{[1
,2
]}

Chen, L-T ^{[3
,4
,5
]}

Von Hoff, D. D. ^{[6
,7
]}

Li, C-P ^{[8
,9
]}

Wang-Gillam, A. ^{[10
]}

Bodoky, G. ^{[11
]}

Dean, A. ^{[12
]}

Shan, Y-S ^{[5
]}

Jameson, G. ^{[6
,7
]}

Macarulla, T. ^{[13
,14
]}

Lee, K-H ^{[15
]}

Cunningham, D. ^{[16
]}

Blanc, J-F ^{[17
]}

Hubner, R. A. ^{[18
]}

Chiu, C-F ^{[19
]}

Schwartsmann, G. ^{[20
]}

Braiteh, F. ^{[21
]}

Moyo, V. ^{[22
]}

Belanger, B. ^{[22
]}

Bayever, E. ^{[22
]}

机构：

[1] Univ Hosp Essen, West German Canc Ctr, Essen, Germany

[2] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany

[3] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan

[4] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[5] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Tainan 701, Taiwan

[6] TGen, Phoenix, AZ USA

[7] HonorHealth, Scottsdale, AZ USA

[8] Taipei Vet Gen Hosp, Taipei, Taiwan

[9] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan

[10] Washington Univ, Sch Med, St Louis, MO USA

[11] St Laszlo Teaching Hosp, Budapest, Hungary

[12] St John God Hosp, Subiaco, WA, Australia

[13] Vall dHebron Univ Hosp HUVH, Barcelona, Spain

[14] VHIO, Barcelona, Spain

[15] Seoul Natl Univ Hosp, Seoul 110744, South Korea

[16] Royal Marsden Hosp, London, England

[17] Hop St Andre, Bordeaux, France

[18] Christie NHS Fdn Trust, Manchester, Lancs, England

[19] China Med Univ Hosp, Taichung, Taiwan

[20] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil

[21] Comprehens Canc Ctr Nevada, Las Vegas, NV USA

[22] Merrimack Pharmaceut, Cambridge, MA USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

0596

引用

页码：170 / 170

页数：1